This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Rising on Monster Volume

Amylin Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Amylin Pharmaceuticals (AMLN) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. This stock is trading up 11.5% at $25.58 in recent trading.

Today's Volume: 9.7 million

Average Volume: 5.15 million

Volume % Change: 207%

>>5 Big Stocks to Trade or Gains

Shares of AMLN are surging higher today after a report hit the wires that the company is reaching out to potential buyers about a possible sale. Reuters said that AMLN is looking for buyers and has hired Credit Suisse and Goldman Sachs as financial advisers.

From a technical perspective, AMLN is gapping up sharply today on monster volume. This move is quickly pushing the stock within range of triggering a big breakout trade. That trade will hit once AMLN can manage to move or close above some near-term overhead resistance at $25.84 with high-volume.

Traders should now look for long-biased traders in AMLN as long as this stock is trending above $25.84 with strong upside volume flows. I would consider any upside volume day that registers near or above 5.15 million shares as strong. Look for AMLN to close near or above its daily high today of $25.96 as a sign that the upside momentum will continue in the short-term.

A possible target is $30 if we get a strong close, and we continue to see AMLN trending above $25.84 with strong upside volume flows.
4 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BEAV $40.69 0.00%
GRPN $2.89 0.00%
SCSS $15.58 0.00%
SNDK $67.49 0.00%
AAPL $93.99 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs